Hirotsugu Tanaka Selected Research

Hirotsugu Tanaka Research Topics

8	Type 2 Diabetes Mellitus (MODY) 01/2014 - 10/2010
2	Insulin Resistance 09/2013 - 03/2011
1	Arthritis (Polyarthritis) 01/2023
1	Experimental Arthritis 01/2023
1	Back Pain (Backache) 01/2023
1	Edema (Dropsy) 01/2023
1	Osteoarthritis 01/2023
1	Chronic Pain 01/2023
1	Pain (Aches) 01/2023
1	Thrombosis (Thrombus) 09/2020
1	Fibrosis (Cirrhosis) 09/2020
1	Hypoglycemia (Reactive Hypoglycemia) 11/2010
1	Hypertriglyceridemia 10/2010

3	Insulin (Novolin)FDA Link 09/2013 - 11/2010
3	Glucose (Dextrose)FDA LinkGeneric 03/2011 - 10/2010
2	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 02/2013 - 10/2010
1	SodiumIBA 01/2023
1	Nerve Growth Factor (NGF)IBA 01/2023
1	Analgesics (Analgesic Drugs)IBA 01/2023
1	AntibodiesIBA 01/2023
1	Immunoglobulin G (IgG)IBA 01/2023
1	Plasminogen Activator Inhibitor 1IBA 09/2020
1	Plasminogen Activators (Plasminogen Activator)IBA 09/2020
1	Dipeptidyl-Peptidase IV InhibitorsIBA 01/2014
1	bis(2- ((4- ((4'- (2- hydroxyethoxy)- 2'- methyl(1,1'- biphenyl)- 3- yl)methoxy)phenyl)methyl)- 3,5- dioxo- 1,2,4- oxadiazolidine)IBA 09/2013
1	SecretagoguesIBA 03/2011
1	2- (4- bromophenyl)- 6- methyl- N- (2- (1- oxidopyridin- 3- yl)ethyl)pyrimidin- 4- amineIBA 11/2010
1	Glyburide (Glibenclamide)FDA LinkGeneric 11/2010
1	2- cyclopentyl- N- (2,4- dichloro- 3- ((isoquinolin- 5- yloxy)methyl)phenyl)- N- methylacetamideIBA 10/2010
1	Blood Glucose (Blood Sugar)IBA 10/2010
1	Triglycerides (Triacylglycerol)IBA 10/2010
1	Hypoglycemic Agents (Hypoglycemics)IBA 10/2010
1	AS 1907417IBA 10/2010

1	Therapeutics 09/2013